INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy

Clinical trial NCT00153088 · COMPLETED

Trial details

NCT number: NCT00153088
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Nephropathies

Start date: 2003-01-01
Primary completion: 2005-11-01
Enrollment: 527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.